NAGIOS: RODERIC FUNCIONANDO

Continuous neurophatic orofacial pain: a retrospective study of 23 cases

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

Continuous neurophatic orofacial pain: a retrospective study of 23 cases

Mostra el registre parcial de l'element

dc.contributor.author Sotorra Figuerola, Dídac es
dc.contributor.author Sánchez Torres, Alba es
dc.contributor.author Valmaseda Castellón, E. es
dc.contributor.author Gay Escoda, Cosme es
dc.date.accessioned 2016-05-26T09:33:02Z
dc.date.available 2016-05-26T09:33:02Z
dc.date.issued 2016 es
dc.identifier.citation Sotorra Figuerola, Dídac ; Sánchez Torres, Alba ; Valmaseda Castellón, E. ; Gay Escoda, Cosme. Continuous neurophatic orofacial pain: a retrospective study of 23 cases. En: Journal of Clinical and Experimental Dentistry, 2016, Vol. 8, No. 2: 153-159 es
dc.identifier.uri http://hdl.handle.net/10550/53786
dc.description.abstract Background: To determine the clinical characteristics of Continuous Neuropathic Orofacial Pain in patients that suffer Persistent Idiopathic Facial Pain (PIFP), Painful Post-Traumatic Trigeminal Neuropathy (PPTTN) or Burning Mouth Syndrome (BMS) and to describe their treatment. Material and Methods: A retrospective observational study was made, reviewing the clinical history of the patients diagnosed with Continuous Neuropathic Orofacial Pain between 2004 and 2011 at the Orofacial Pain Unit of the Master of Oral Surgery and Implantology of the University of Barcelona and at the Orofacial Pain Unit of the Teknon Medical Center of Barcelona. Results: The average age of the patients with Continuous Neuropathic Orofacial Pain was 54.5, with a clear female predominance (86.9%, n=20). Of all patients, 60.9% (n=14) were suffering a PIFP, 21.7% (n=5) had a BMS and 17.4% (n=4) were presenting a PPTTN. The pain quality described by the patients with Continuous Neuropathic Orofacial Pain was oppressive (43.47%, n=10), widely represented by patients with PIFP, and burning (39.13%, n=9) being the only quality that described patients with BMS. The treatment carried out with the patients was only pharmacologic. The most used drugs for the treatment of PIFP and PPTTN were clonazepam (50%, n=9) and amitriptyline (44.44%, n=8). However, a 55.5% (n=10) of the patients with PIFP or PPTTN required the association of two or more drugs for a correct pain control. All the patients with BMS responded satisfactorily to clonazepam. Conclusions: Continuous Neuropathic Orofacial Pain is a little known condition among the general population, physicians and dentists. This favors a late diagnosis and inaccurate treatments which entail unnecessary suffering. It is important to inform both the general population and health professionals concerning this painful condition. en_US
dc.subject Odontología es
dc.subject Ciencias de la salud es
dc.title Continuous neurophatic orofacial pain: a retrospective study of 23 cases es
dc.type journal article es_ES
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.type.hasVersion VoR es_ES

Visualització       (650.9Kb)

Aquest element apareix en la col·lecció o col·leccions següent(s)

Mostra el registre parcial de l'element

Cerca a RODERIC

Cerca avançada

Visualitza

Estadístiques